Pentwater Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Pentwater Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,000,000	Closed	-$202M	–	103
2026 Q1	$202M	Buy	14,000,000 +2,500,000	+22%	+$35.8M	1.05%	22
2025 Q4	$164M	Buy	+11,500,000	New	+$113M	0.86%	21

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Pentwater Capital Management's FOLD Position: Q2 2026 in Review

Pentwater Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 14,000,000 shares — an estimated $202M sold.

Pentwater Capital Management first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $202M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Pentwater Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Pentwater Capital Management sold 14,000,000 Amicus Therapeutics shares in Q2 2026, an estimated $202M.
Pentwater Capital Management first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Pentwater Capital Management's Amicus Therapeutics position peaked at $202M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.